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Abstract
Background: The spermatogenesis system includes highly radiosensitive cells. Hence,
this system is a potential target for toxic effects of ionizing radiation during radiotherapy
of abdomen and pelvis cancers, as well as after accidental radiation events.
Accordingly, metformin and melatonin are two important radioprotectors that have
shown an ability to prevent cell death through neutralization of free radicals and
stimulating DNA damage responses.
Objective: To evaluate the radioprotective effects of melatonin and metformin on mice
spermatogenesis when administered alone or as a combination.
Materials and Methods: In this histological Study, 40 (6-8 wk, 30 gr) NMRI
mice were divided into 8 groups (n = 5/each) as control, metformin, melatonin,
melatonin + metformin, radiation, radiation + melatonin, radiation + metformin, and
radiation + melatonin + metformin. 37 days after the irradiation, the testicular tissues
were collected for histological evaluation.
Results: Single administration of melatonin could ameliorate effectively radiation
toxicity in mice testis. Metformin showed radioprotective effects on some parameters
such as the numbers of spermatogonia andmature sperms. Interestingly, themelatonin
and metformin combination reversed the reduced number of sperms rather than single
drug administration.
Conclusion: The combination of melatonin with metformin can protect mice
spermatogenesis against ionizing radiation more effectively compared to the single
forms of these drugs.
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1. Introduction
In today’s world, ionizing radiation plays a vital
role in human life. Medical applications of ionizing
radiation including radiotherapy and diagnostic
radiology are major benefits of radiation to man. It
has also been utilized for agricultural and industrial
purposes (1). Besides the useful applications of
radiation, its exposure could lead to detrimental
consequences to the human body. The major aim
of radiotherapy is tumor eradication. However,
it has been associated with toxicity to adjacent
organs (2). In addition to the useful applications of
ionizing radiation, there has also been the threat
of its use for terror aims, as well as accidental
radiation events such as explosions from nuclear
stations (3). Bone marrow hematopoietic cells,
gastrointestinal and spermatogenesis systems are
the most radiosensitive organs. Depletion of stem
cells in the bone marrow and gastrointestinal
system occurs following exposure to radiation
doses higher than 4 Gy, which may lead to
death (4). However, spermatogenic arrest may be
observed following exposure to lower radiation
doses (5). The testis is made up of various cell
types with different characteristics. It has been
proposed that the spermatogonia (germinal cells
within the testis) are the most radiosensitive cells
(6). The spermatogonia differentiate to spermatids,
which produce spermatocytes and finally mature
sperm cells. In addition to spermatogonia, other
cells are highly sensitive to radiation with lethal
dose 37% (LD 37%) lower than 1 Gy (7). Hence,
exposure to sublethal doses of radiation (1-4
Gy), which is common during radiotherapy or a
radiation disaster, can lead to potent suppression
of spermatogenesis. This issue is very important
for patients with pelvic cancers, whereby the testis
is within or adjacent to the radiation field (8). One
of the most common and easiest strategies for
amelioration of toxic damage to spermatogenesis
in response to radiation exposure is the use of
some agents which reduce radiation-induced DNA
damages as well as cell death (9).
In the present study, we examined the possible
protective effects of melatonin and metformin
against radiation-induced mice spermatogenesis
injury.
2. Materials and Methods
2.1. Experimental design
In this experimental study, 40 NMRI mice
(6-8 wk, 30 gr) were divided into eight groups
as follows (n = 5/each); G1 (control) recieved
only ketamine and xylazine for anesthesia
similar to other groups; G2 (metformin treated)
received only 100 mg/kg metformin; G3 (melatonin
treated) received only 100 mg/kg melatonin;
G4 (melatonin + metformin) received 100 mg/kg
metformin + 100 mg/kg melatonin; G5: (radiation
only group) were irradiated with 2 Gy gamma rays
to whole body without any drug treatment; G6:
(radiation and metformin) were irradiated locally
to pelvis area with 2 Gy gamma rays and also
received 100 mg/kg metformin; G7 (radiation and
melatonin were irradiated locally to pelvis area
with 2 Gy gamma rays and also received 100
mg/kg melatonin; G8 (radiation and combination
of melatonin and metformin) were irradiated locally
to pelvis area with 2 Gy gamma rays and also
received metformin and melatonin at 100 mg/kg.
Next, 37 days after the irradiation, all mice were
sacrificed. Their right testes were then removed
and fixed in Bouin’s solution for histopathological
evaluation.
2.2. Drugs and irradiation
Melatonin provided from Merck company
(Germany). Melatonin powder dissolved in
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ethanol and then diluted in distilled water.
Final our solution was included 15% ethanol
and the concentration of melatonin was 3 mg
per each milliliter. Metformin was purchased
from Tehran Chiemi Company, Tehran, Iran.
As metformin is soluble in water, it dissolved
in distilled water at a similar concentration.
For preparing the melatonin and metformin
combination, melatonin was first dissolved in
ethanol, and then diluted in distilled water.
Afterward, metformin was added to the melatonin
solution. The concentration of both melatonin and
metformin was 3 mg/ml. Treatments commenced
two days before irradiation at one dose/day. The
last treatment was administered 30 min before
irradiation. Beside, melatonin and metformin as
well as their combination were administered
orally at 100 mg/kg. These drug doses were
chosen similar to some previous animal studies
(10, 11).
Irradiation was done by a cobalt-60 (60°C)
gamma rays source. Before irradiation, all mice
were anesthetized using ketamine and xylazine
of doses 80 and 5 mg/kg, respectively. Next,
the mice were positioned supine and irradiated
with 60°C gamma rays (1.25 MeV). Irradiation was
done with 2 Gy gamma rays at a dose rate
of 60 cGy/min as a single dose. The selection
of 2 Gy dose of radiation was based on a
previous study on murine spermatogenesis system
(12).
2.3. Histopathology
Tissue samples were provided for light
microscopy examination according to standard
procedures. The testes were then fixed in Bouin’s
solution, then, provided as small piecesin
paraffin wax. These samples sectioned at
3 μm, and then stained with hematoxylin
and eosin (a common method for evaluating
morphological changes) and PAS special
staining (for assessment of basement membrane
thickness). Testis tissue slides were evaluated
for common morphological changes in
spermatogenesis including numbers of sperms
and spermatogonia, spermatogenic arrest,
damage to seminiferous tubules, interstitial edema,
Leydig cell hyperplasia (13-15), and Johnsen
scoring (16). The results of histopathological
evaluation were reported using the following
scores: normal = 0; mild = 1; moderate = 2; and
severe = 3.
2.4. Ethical consideration
This study was approved by the Tehran
University of Medical Sciences, under ethical
code: IR.TUMS.MEDICINE.REC.1396.3787. All
mice received enough anesthesiza drugs
before scarification to prevent a painful
death.
2.5. Statistical analysis
After scoring, results were reported as
mean ± standard deviation (mean ± SD). To
determine the statistical significance between
groups, the SPSS software version 16 (IBM
Chicago, USA) was used. Additionally, the
Mann-Whitney test was performed to analyze
the statistical differences between groups. P-
value < 0.05 was considered as statistically
significant.
3. Results
Our assesments confirmed that exposure
of mice to 2 Gy gamma rays causes mild to
severe damages to spermatogenesis system.
Irradiation also gave rise to moderate atrophy
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of seminiferous tubules, interstitial edema,
and Leydig cell hyperplasia. Treatment with
melatonin or its combination with metformin
was able to ameliorate atrophy of seminiferous
tubules, while administering metformin alone
could not protect them. Neither drug could
mitigate interstitial edema, although they
could reduce radiation-induced Leydig cell
hyperplasia. In addition, treatment with drugs
did not show any effect on spermatogenic arrest,
while irradiation led to mild thickening of basal
lamina. Basal lamina thickening was ameliorated
with melatonin as well as its combination
with metformin; however, metformin treatment
alone could not mitigate it. Irradiation caused
severe reduction of spermatogonia numbers
and Johnsen score. Treatment with melatonin,
metformin, as well as their combination was
able to alleviate these reductions. Histological
evaluation of epididymis showed a severe
vacuolation with no detectable mature sperm.
Mice treated with melatonin or metformin had
few spermatozoa. Interestingly, mice treated with
the combination of melatonin and metformin
showed normal epididymis (Figure 1, Table
I).
Table I. Results of morphological changes following irradiation with or without melatonin, metformin or their combination in mice
testes




0.00 ± 00 0.00 ± 00 0.00 ± 00 0.00 ± 00 2.00 ± 1.0𝑎 0.80 ± 0.83𝑏 1.00 ± 00 0.60±0.54𝑏,𝑐
Interstitial




0.00 ± 00 0.00 ± 00 0.00 ± 00 0.00 ± 00 4.00 ± 00𝑎 0.00 ± 00 0.00 ± 00 0.00 ± 00
Thickening of
basal lamina 0.00 ± 00 0.00 ± 00 0.00 ± 00 0.00 ± 00 1.00 ± 00
𝑎 0.44±0.20𝑏,𝑐 1.00 ± 00 0.44±0.20𝑏,𝑐
Leydig cell
hyperplasia 0.00 ± 00 0.00 ± 00 0.33 ± 0.57 0.40± 0.54 2.00 ± 00




325 ± 27 337 ± 13 327 ± 11 325 ± 39 74 ± 9𝑎 187 ± 11𝑏,𝑐 154 ± 8𝑏 199 ± 11𝑏,𝑐
Johnsen
scoring 8.80 ± 0.44 9.00 ± 0.70 8.60± 0.54 8.60± 0.54 4.00 ± 00
𝑎 6.80 ± 1.09𝑏 7.00 ± 1.15𝑏 7.28 ± 0.95𝑏
Epididymis








Data presented as Mean ± SD. Mann-Whitney test, p < 0.05, 𝑎 Significant compared to control group; 𝑏 Significant compared to
radiation (RAD) group; 𝑐 Significant compared to radiation + metformin (RAD + MET) group. Comparisons between RAD + MLT
and RAD + MLT + MET was not significant, MLT: Melatonin, MET: Metformin, RAD: Radiation
Page 1076 https://doi.org/10.18502/ijrm.v18i12.8029
International Journal of Reproductive BioMedicine Radioprotective effect of melatonin and metformin on spermatogenesis
Figure 1. (A-H) Photomicrographs of radioprotective effect of melatonin, metformin, and their combination on mice
spermatogenesis. (H and E ×1000) (A) Normal spermatogenesis in the control group, JS* = 9; (B) Spermatogenesis in melatonin
group, average JS* = 9-10; (C) Spermatogenesis within normal limit in metformin group, average JS* = 9-10; (D) Spermatogenesis
in melatonin + metformin group, JS* = 9; (E) Nearly all lineage of spermatogonial cells were damaged in the radiation only group.
Severe tubular atrophy, decreased number of germ cells per tubules (round empty spaces), and few spermatocytes were present,
JS* = 4; (F) Moderate decrease in spermatogenesis with only few spermatids in the radiation + melatonin group, JS* = 6; (G) Mild
decrease in the number of germ cells within seminiferous tubules in the radiation + metformin group. A few spermatids were
present (marked with arrow), JS* = 7; (H) Sub-normal spermatogenesis in the radiation + melatonin + metformin group, some
spermatozoa are seen within the lumen (marked with arrow), average JS* = 8. *Johnsen scoring.
4. Discussion
Ionizing radiation has potent detrimental
effects on spermatogenesis system. A low to
mild dose of radiation is able to destroy normal
spermatogenesis via induction of apoptosis in
germ cells and spermatogonia. Even a sublethal
dose of ionizing radiation (e.g., 1-4 Gy) can
cause temporary or permanent infertility. Hence,
exposure to a sublethal dose of radiation such
as seen in accidental nuclear or radiological
events can cause potent inhibition of the
reproductive system (17). Moreover, during
pelvic or abdomen radiotherapy, scattered
radiation is able to cause massive damage to
spermatogenesis. The changes in the level of sex
hormones such as follicle-stimulating hormone
and testosterone amplifies spermatogenesis
damage following radiotherapy (18). Low level of
testosterone following low- and high doses of
ionizing radiation can disrupt maturation of primary
spermatids. Decreased testosterone in association
with unusual follicle-stimulating hormone and
luteinizing hormone can be a sign of damage
to spermatogenesis, which can be observed in
patients that have undergone radiotherapy for
pelvic cancers (19).
To Infertility isn’t only concern, and exposure of
the testis to ionizing radiation may increases risk
of carcinogenesis in future generations. Several
experiments have confirmed some evidences
for delayed consequences of radiation in next
generation of irradiated cells. These pieces of
evidence indicate that radiation induces cancer in
future generations of irradiated cells. Furthermore,
an increase in the expression of oncogenes has
reported in the next generation (20). The highly
radiosensitive nature of spermatogenesis system
has been confirmed among people who were
exposed to sublethal doses of radiation. Møller
and colleagues showed that the frequency of
aberrant morphology in the sperms of Chernobyl
survivors was higher than normal levels. They
also showed that this has a direct relationship
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with serum level of antioxidants, including retinol,
α-tocopherol, and carotenoids (21). Another
study showed changes in the characteristics of
sperm function, increased DNA damage, and
hypermethylation among radiation workers (22).
Due to the high radiosensitivity of spermatogenesis
system, several studies have been conducted
to introduce a safe drug or other agents for
protection against ionizing radiation. Previous
studies have revealed that antioxidants such as
ascorbic acid and alpha-tocopherol can protect
against ionizing radiation-induced toxic damage to
spermatogenesis (12, 23).
Our results showed that whole body exposure
to radiation led to damage to seminiferous
tubules and epididymis, edema in interstitial,
and remarkable damage to spermatogenesis and
Leydig cells. Severe damage to spermatogonia and
reduction in the numbers of spermatids and sperms
are signs of spermatogenic arrest, which was
obvious following irradiation. In the present study,
we showed that the combination of melatonin
and metformin has a potent radioprotection
on mice spermatogenesis without a significant
cytotoxicity. Melatonin is a pineal hormone,
regulated in a circadian manner, however, several
studies have suggested other regulatory roles
for it. Melatonin, as a drug, is used to improve
sleep. Also, the use of melatonin as an adjuvant
for other diseases may lead to drowsiness (24).
Studies have shown that melatonin is able to
neutralize different types of free radicals directly
or via activation of antioxidant enzymes such
as superoxide dismutase (SOD), glutathione
(GSH), glutathione peroxidase (GPx), catalase
(CAT), and glutathione reductase (GR) (25).
Several bodies of evidence have suggested
that melatonin inhibits reduction/oxidation
reactions following exposure to radiation,
leading to inhibition of chronic oxidative stress
in irradiated cells (26). A systematic review by
Zetner and colleagues proposed that melatonin
can be potentially used for cancer patients
undergoing radiotherapy (27). The differential
effect of melatonin on normal tissues against
some cancer cells also make it a potential
adjuvant for both radioprotection of normal
tissues and radiosensitization of cancers (25).
Administration of melatonin before exposure to
ionizing radiation has been shown to reduce
apoptosis in rat’s testis and attenuates the
expression of caspase-3 in primary spermatocytes
(28). The administration of melatonin has also
been shown to ameliorate damage to Sertoli cells.
Furthermore, it induces antioxidant defense and
increases proliferation of spermatogenesis, which
lead to reduction of toxicity in testis following
irradiation or exposure to chemotherapy (29,
30).
Metformin is another agent that has shown
promising radioprotective effects. It is an FDA-
approved antidiabetic drug which is used by
millions of people worldwide. Metformin has shown
ability to scavenge free radicals and stimulate
antioxidant enzymes, thus reducing apoptosis and
genotoxicity, leading to amelioration of cell death
(31). In addition, via inhibition of electron transfer
chain 1 (ETC1) in the mitochondria, it attenuates
redox activity and continuous production of
superoxide bymitochondria during oxidative stress
conditions (32). Emerging evidence shows that in
addition to reducing the risk of carcinogenesis,
metformin can also be proposed as an adjuvant
in cancer therapy (33). It is important to note
that metformin also has some side effects. The
most important side effects include hypoglycemia
and weakness, however, in some situation it
may cause lactic acidosis, pain, or infection
(34). A previous study showed that metformin
is able to reduce apoptosis and damage to
basal lamina following ischemia/reperfusion
in rats (35). Results of this study showed that
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melatonin, when administered alone or in
combination with metformin, can ameliorate
all evaluated damages except interstitial edema.
Metformin also showed an ability to increase
the numbers of spermatogonia and mature
sperms, as well as alleviate damages to Leydig
cells. The effect of the combination of melatonin
with metformin was similar to that of melatonin
administered alone. However, the combination
was more potent in preserving mature sperms
compared with melatonin or metformin alone.
Moreover, single treatment with melatonin was
more potent compared to that of metformin in
preserving most of the spermatogenic activity.
It seems that via stimulation of DNA damage
repair, melatonin and metformin were able to
protect the spermatogonia and other testicular
cells such as spermatids, spermatocytes, and
Leydig cells against massive DNA damage and
cell death. Interestingly, results of histological
evaluation suggest that the combination of
both melatonin and metformin may have a
synergic effect in protecting these progenitor
cells against the clastogenic effects of ionizing
radiation.
5. Conclusion
This study showed that the combination
of melatonin with metformin can protect
against ionizing radiation-induced damage to
spermatogenesis more effectively compared to
the single forms of these drugs. Moreover, results
of this study showed that the radioprotective
effect of melatonin is more potent compared to
metformin’s. It is possible that the combination
of these drugs has a synergic effect on the
protection of immature spermatogonia or other
sperm progenitor cells against genotoxic effects of
ionizing radiation, however, this will require further
studies.
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